Drug Type Enzyme |
Synonyms ICV-ERT(BioMarin Pharmaceutical) |
Target |
Mechanism Heparan sulfate sulfatase replacements, β-galactosidase replacements(Beta-galactosidase replacements) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gangliosidosis, GM1 | Preclinical | US | 01 Sep 2020 |